AI Health Index
Vendors · Drug Discovery AI · XtalPi
X

XtalPi pricing

Drug discovery work is sold as services and partnerships with upfront payments, research funding, milestones and royalties negotiated per deal, and lab automation systems and software route to a contact form. As a Hong Kong listed company XtalPi reports segment revenue (about 266 million yuan in 2024, with the robotics line larger than drug discovery) and announces deal values, such as the DoveTree Medicines collaboration at up to $5.99 billion in upfront and milestone payments and a GPCR program above $400 million in total potential value. Those figures describe what the company earned and what particular partners negotiated, not a price a new partner or robotics buyer can apply.

XtalPi full profileXtalPi alternatives
Pricing terms

How XtalPi pricing works

Pricing model
Two revenue lines: drug discovery collaboration with upfront payments, research funding, milestones and royalties; and intelligent robotics systems sold to enterprise and research clients
Implementation
Lab automation systems are installed on customer sites with customizable deployments; installation and integration fees are not published.
Compared on price

XtalPi pricing against its alternatives

Published prices for XtalPi and the products closest to it. Each figure is as the vendor publishes it, in its own currency and billing unit.

All XtalPi alternatives →

Questions

XtalPi pricing, answered

How much does XtalPi cost?

XtalPi does not publish a price. Drug discovery work is sold as services and partnerships with upfront payments, research funding, milestones and royalties negotiated per deal, and lab automation systems and software route to a contact form.

Does XtalPi charge an implementation fee?

Lab automation systems are installed on customer sites with customizable deployments; installation and integration fees are not published.